Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Main Reason for Merger Is to Add Value: Mr Burns of Roche
December 24, 2001
- Steroid Nasal Drops Effective against Japanese Cedar Pollinosis: GSK Seminar
December 24, 2001
- FPMAJ Proposes Fast Track System -1-
December 24, 2001
- Nearly 50% of Physicians Want Increased MTX Doses for RA: Society Meeting
December 24, 2001
- FPMAJ Proposes Fast Track System -2-
December 24, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
December 24, 2001
- BUSINESS NEWS IN BRIEF
December 17, 2001
- Actelion Sets Up Japanese Subsidiary with 2 ERAs: Dr Widmann
December 17, 2001
- Combined Sales of 12 Major Wholesalers Up 15.7%, Net Profits Down 50.2%
December 17, 2001
- Mean Price Discrepancy Rate Is 7.1%: Drug Price Survey
December 17, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
December 17, 2001
- Latest Proposals for NHI Price System Reform Explained
December 17, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 17, 2001
- Employees' Copayment to Be Raised to 30% "When Necessary"
December 17, 2001
- WORLD NEWS I N BRIEF
December 17, 2001
- Basic Policy for FY2002 Budget Approved
December 17, 2001
- 1st Large Epidemiologic Study on Arteriosclerotic Disease to Start in Japan
December 17, 2001
- Medical Fees to Be Reduced: The Question Is How Much
December 17, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
December 17, 2001
- Domestic Drug Production Down 1.7% to \6,18 Trillion in FY2000
December 17, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…